Lista de obras -

A Bivalent Vaccine Based on a PB2-Knockout Influenza Virus Protects Mice From Secondary Pneumococcal Pneumonia

artículo científico publicado en 2015

A Highly Pathogenic Avian H7N9 Influenza Virus Isolated from A Human Is Lethal in Some Ferrets Infected via Respiratory Droplets

artículo científico publicado en 2017

A bivalent vaccine based on a replication-incompetent influenza virus protects against Streptococcus pneumoniae and influenza virus infection

artículo científico publicado en 2014

A cross-reactive neutralizing monoclonal antibody protects mice from H5N1 and pandemic (H1N1) 2009 virus infection ⬇️

artículo científico publicado el 16 de septiembre de 2010

A novel M cell-specific carbohydrate-targeted mucosal vaccine effectively induces antigen-specific immune responses

artículo científico publicado en 2007

A novel bivalent vaccine based on a PB2-knockout influenza virus protects mice from pandemic H1N1 and highly pathogenic H5N1 virus challenges

artículo científico publicado en 2013

A protective immune response in mice to viral components other than hemagglutinin in a live influenza A virus vaccine model

artículo científico publicado en 2004

A replication-incompetent influenza virus bearing the HN glycoprotein of human parainfluenza virus as a bivalent vaccine

artículo científico publicado en 2013

A replication-incompetent virus possessing an uncleavable hemagglutinin as an influenza vaccine

artículo científico publicado en 2012

Antigenic differences between H5N1 human influenza viruses isolated in 1997 and 2003.

artículo científico publicado en 2004

Antigenic variants of influenza B viruses isolated in Japan during the 2017-2018 and 2018-2019 influenza seasons

scientific article published on 19 January 2020

Avian-type receptor-binding ability can increase influenza virus pathogenicity in macaques

artículo científico publicado en 2011

Cats as a potential source of emerging influenza virus infections

artículo científico publicado en 2015

Characterization of H7N9 influenza A viruses isolated from humans.

artículo científico publicado en 2013

Cross-clade protective immunity of H5N1 influenza vaccines in a mouse model.

artículo científico publicado en 2008

Cytokine production by primary human macrophages infected with highly pathogenic H5N1 or pandemic H1N1 2009 influenza viruses

artículo científico publicado en 2011

Development of an Influenza Rapid Diagnostic Kit Specific for the H7 Subtype.

artículo científico publicado en 2018

Differences in cytokine production in human macrophages and in virulence in mice are attributable to the acidic polymerase protein of highly pathogenic influenza A virus subtype H5N1.

artículo científico publicado en 2012

Diversity of antigenic mutants of influenza A(H1N1)pdm09 virus escaped from human monoclonal antibodies

artículo científico publicado en 2017

Emergence of Oseltamivir-Resistant H7N9 Influenza Viruses in Immunosuppressed Cynomolgus Macaques

artículo científico publicado en 2017

Enhanced growth of seed viruses for H5N1 influenza vaccines

artículo científico publicado en 2007

Evaluation of the fusion partner cell line SPYMEG for obtaining human monoclonal antibodies against influenza B virus.

artículo científico publicado en 2018

Experimental infection of Cynomolgus Macaques with highly pathogenic H5N1 influenza virus through the aerosol route.

artículo científico publicado en 2018

Generation of influenza A virus NS2 (NEP) mutants with an altered nuclear export signal sequence

artículo científico publicado en 2004

Generation of influenza A viruses with chimeric (type A/B) hemagglutinins

artículo científico publicado en 2003

Growth determinants for H5N1 influenza vaccine seed viruses in MDCK cells

artículo científico publicado en 2008

Hierarchy among viral RNA (vRNA) segments in their role in vRNA incorporation into influenza A virions

artículo científico publicado en 2006

Highly Pathogenic Avian Influenza Virus Infection in Feral Raccoons, Japan ⬇️

artículo científico publicado el 1 de abril de 2011

Improved neutralizing antibody response in the second season after a single dose of pandemic (H1N1) 2009 influenza vaccine in HIV-1-positive adults

artículo científico publicado en 2012

Incorporation of influenza A virus genome segments does not absolutely require wild-type sequences

artículo científico publicado en 2009

Induction of TNF-alpha in human macrophages by avian and human influenza viruses

artículo científico publicado en 2010

Influenza A (H5N1) Viruses from Pigs, Indonesia ⬇️

artículo científico publicado el 1 de octubre de 2010

Influenza A variants with reduced susceptibility to baloxavir isolated from Japanese patients are fit and transmit through respiratory droplets

scientific article published on 25 November 2019

Influenza A viruses possessing type B hemagglutinin and neuraminidase: potential as vaccine components

artículo científico publicado en 2004

Limited compatibility between the RNA polymerase components of influenza virus type A and B.

artículo científico publicado en 2008

Molecular characterization of the hemagglutinin and neuraminidase genes of H5N1 influenza A viruses isolated from poultry in Vietnam from 2004 to 2005.

artículo científico publicado en 2006

Mutation analysis of 2009 pandemic influenza A(H1N1) viruses collected in Japan during the peak phase of the pandemic

artículo científico publicado en 2011

Nucleotide sequence requirements at the 5' end of the influenza A virus M RNA segment for efficient virus replication

scientific article published on 21 January 2009

Selection of antigenically advanced variants of seasonal influenza viruses

artículo científico publicado en 2016

Seroprevalence of Pandemic 2009 (H1N1) Influenza A Virus among Schoolchildren and Their Parents in Tokyo, Japan ⬇️

artículo científico publicado el 23 de febrero de 2011

Significance of seasonal influenza viruses in the stool of pediatric patients

artículo científico publicado en 2010

Structure-based design of NS2 mutants for attenuated influenza A virus vaccines ⬇️

artículo científico publicado el 21 de octubre de 2010

Syrian hamster as an animal model for the study of human influenza virus infection

artículo científico publicado en 2017

The ASK family kinases differentially mediate induction of type I interferon and apoptosis during the antiviral response

artículo científico publicado en 2015

The HA and NS Genes of Human H5N1 Influenza A Virus Contribute to High Virulence in Ferrets ⬇️

artículo científico publicado el 16 de septiembre de 2010

The Marmoset as an Animal Model of Influenza: Infection With A(H1N1)pdm09 and Highly Pathogenic A(H5N1) Viruses via the Conventional or Tracheal Spray Route.

artículo científico publicado en 2018

The Microminipig as an Animal Model for Influenza A Virus Infection

artículo científico publicado en 2016

The SARS-CoV-2 B.1.1.529 Omicron virus causes attenuated infection and disease in mice and hamsters

The cytoplasmic tail of the influenza A virus M2 protein plays a role in viral assembly

artículo científico publicado en 2006

The development and characterization of H5 influenza virus vaccines derived from a 2003 human isolate.

artículo científico publicado en 2005

The index influenza A virus subtype H5N1 isolated from a human in 1997 differs in its receptor-binding properties from a virulent avian influenza virus

artículo científico publicado en 2004

Unadjuvanted pandemic H1N1 influenza vaccine in HIV-1-infected adults

artículo científico publicado en 2011

Virulence determinants of pandemic A(H1N1)2009 influenza virus in a mouse model

artículo científico publicado en 2012

Lista de obras de

A Bivalent Vaccine Based on a PB2-Knockout Influenza Virus Protects Mice From Secondary Pneumococcal Pneumonia

A Highly Pathogenic Avian H7N9 Influenza Virus Isolated from A Human Is Lethal in Some Ferrets Infected via Respiratory Droplets

A bivalent vaccine based on a replication-incompetent influenza virus protects against Streptococcus pneumoniae and influenza virus infection

A cross-reactive neutralizing monoclonal antibody protects mice from H5N1 and pandemic (H1N1) 2009 virus infection ⬇️

A novel M cell-specific carbohydrate-targeted mucosal vaccine effectively induces antigen-specific immune responses

A novel bivalent vaccine based on a PB2-knockout influenza virus protects mice from pandemic H1N1 and highly pathogenic H5N1 virus challenges

A protective immune response in mice to viral components other than hemagglutinin in a live influenza A virus vaccine model

A replication-incompetent influenza virus bearing the HN glycoprotein of human parainfluenza virus as a bivalent vaccine

A replication-incompetent virus possessing an uncleavable hemagglutinin as an influenza vaccine

Antigenic differences between H5N1 human influenza viruses isolated in 1997 and 2003.

Antigenic variants of influenza B viruses isolated in Japan during the 2017-2018 and 2018-2019 influenza seasons

Avian-type receptor-binding ability can increase influenza virus pathogenicity in macaques

Cats as a potential source of emerging influenza virus infections

Characterization of H7N9 influenza A viruses isolated from humans.

Cross-clade protective immunity of H5N1 influenza vaccines in a mouse model.

Cytokine production by primary human macrophages infected with highly pathogenic H5N1 or pandemic H1N1 2009 influenza viruses

Development of an Influenza Rapid Diagnostic Kit Specific for the H7 Subtype.

Differences in cytokine production in human macrophages and in virulence in mice are attributable to the acidic polymerase protein of highly pathogenic influenza A virus subtype H5N1.

Diversity of antigenic mutants of influenza A(H1N1)pdm09 virus escaped from human monoclonal antibodies

Emergence of Oseltamivir-Resistant H7N9 Influenza Viruses in Immunosuppressed Cynomolgus Macaques

Enhanced growth of seed viruses for H5N1 influenza vaccines

Evaluation of the fusion partner cell line SPYMEG for obtaining human monoclonal antibodies against influenza B virus.

Experimental infection of Cynomolgus Macaques with highly pathogenic H5N1 influenza virus through the aerosol route.

Generation of influenza A virus NS2 (NEP) mutants with an altered nuclear export signal sequence

Generation of influenza A viruses with chimeric (type A/B) hemagglutinins

Growth determinants for H5N1 influenza vaccine seed viruses in MDCK cells

Hierarchy among viral RNA (vRNA) segments in their role in vRNA incorporation into influenza A virions

Highly Pathogenic Avian Influenza Virus Infection in Feral Raccoons, Japan ⬇️

Improved neutralizing antibody response in the second season after a single dose of pandemic (H1N1) 2009 influenza vaccine in HIV-1-positive adults

Incorporation of influenza A virus genome segments does not absolutely require wild-type sequences

Induction of TNF-alpha in human macrophages by avian and human influenza viruses

Influenza A (H5N1) Viruses from Pigs, Indonesia ⬇️

Influenza A variants with reduced susceptibility to baloxavir isolated from Japanese patients are fit and transmit through respiratory droplets

Influenza A viruses possessing type B hemagglutinin and neuraminidase: potential as vaccine components

Limited compatibility between the RNA polymerase components of influenza virus type A and B.

Molecular characterization of the hemagglutinin and neuraminidase genes of H5N1 influenza A viruses isolated from poultry in Vietnam from 2004 to 2005.

Mutation analysis of 2009 pandemic influenza A(H1N1) viruses collected in Japan during the peak phase of the pandemic

Nucleotide sequence requirements at the 5' end of the influenza A virus M RNA segment for efficient virus replication

Selection of antigenically advanced variants of seasonal influenza viruses

Seroprevalence of Pandemic 2009 (H1N1) Influenza A Virus among Schoolchildren and Their Parents in Tokyo, Japan ⬇️

Significance of seasonal influenza viruses in the stool of pediatric patients

Structure-based design of NS2 mutants for attenuated influenza A virus vaccines ⬇️

Syrian hamster as an animal model for the study of human influenza virus infection

The ASK family kinases differentially mediate induction of type I interferon and apoptosis during the antiviral response

The HA and NS Genes of Human H5N1 Influenza A Virus Contribute to High Virulence in Ferrets ⬇️

The Marmoset as an Animal Model of Influenza: Infection With A(H1N1)pdm09 and Highly Pathogenic A(H5N1) Viruses via the Conventional or Tracheal Spray Route.

The Microminipig as an Animal Model for Influenza A Virus Infection

The SARS-CoV-2 B.1.1.529 Omicron virus causes attenuated infection and disease in mice and hamsters

The cytoplasmic tail of the influenza A virus M2 protein plays a role in viral assembly

The development and characterization of H5 influenza virus vaccines derived from a 2003 human isolate.

The index influenza A virus subtype H5N1 isolated from a human in 1997 differs in its receptor-binding properties from a virulent avian influenza virus

Unadjuvanted pandemic H1N1 influenza vaccine in HIV-1-infected adults

Virulence determinants of pandemic A(H1N1)2009 influenza virus in a mouse model